Macquarie Group
RLYB icon

Macquarie Group’s Rallybio RLYB Stock Holding History

Macquarie Group’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-197
Closed -$2.11K – 1864
2024
Q2 		$2.11K Buy
+197
New +$2.67K ﹤0.01% 1798

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group's RLYB Position: Q3 2024 in Review

Macquarie Group sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 197 shares — an estimated $2.11K sold.

Macquarie Group first reported a position in RLYB in Q2 2024 and held it in 1 quarter. The position peaked at $2.11K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

  • Macquarie Group reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
  • Macquarie Group sold 197 Rallybio shares in Q3 2024, an estimated $2.11K.
  • Macquarie Group first reported a position in Rallybio in Q2 2024 and held it in 1 quarter.
  • Macquarie Group's Rallybio position peaked at $2.11K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on Macquarie Group's 13F filing for Q3 2024, filed 14 Nov 2024.